Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

NCT00842673 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: ST101
DRUG: ST101
DRUG: ST101
DRUG: Placebo

Sponsor

Sonexa Therapeutics, Inc.